PTCT PTC Therapeutics, Inc.

HealthcareBiotechnology
$64.49
▼ 3.12%
44
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
37
Short-Term
51

Value

14
P/E-28.50
8
P/B-29.49
5
P/S6.46
40
EV/EBITDA-127.42
5

Growth

85
Revenue Growth114.5%
100
EPS Growth281.4%
62
FCF Growth486.0%
99

Momentum

65
12-Month Return78.2%
100
3-Month Return-10.9%
43
1-Month Return-9.5%
36
RSI (14)27.16
60
50/200 MABullish
75

Profitability

24
ROE99.8%
70
ROA-6.5%
0
Gross Margin49.7%
46
Operating Margin-8.3%
9
Net Margin-22.6%
0
FCF Yield-4.3%
0

Risk

32
Beta0.53
55
60-Day Volatility39.2%
13

Generated 5/7/2026, 10:04:10 PM · How is this calculated?

QScore Analysis